Supernus Pharmaceuticals Inc (SUPN)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SUPN? Forum Prognose

Finanzdaten der Supernus Pharmaceuticals Inc-Aktie (SUPN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.13% 211.57	192.10	165.45	149.82	174.16
Cost Of Revenue	21.31% 23.01	18.96	16.83	15.76	26.10
Gross Profit	8.91% 188.56	173.14	148.63	134.06	148.06
Operating Expenses	17.51% 192.50	233.37	136.49	144.32	126.66
Benefits Costs and Expenses	14.63% 213.49	250.06	148.78	155.66	147.78
Costs And Expenses	14.59% 215.51	252.33	153.31	160.08	152.75
Depreciation and Amortization	0.00% 0.50	0.50	0.50	0.60	0.60
Operating Income/Loss	93.46% -3.937	-60.23	12.14	-10.26	21.41
Nonoperating Income/Loss	11.16% 2.023	2.277	4.528	4.425	4.977
Income/Loss From Continuing Operations Before Tax	96.70% -1.914	-57.95	16.67	-5.831	26.38
Income Tax Expense/Benefit, Deferred	818.45% 19.00	-2.645	-7.162	-3.99	-0.072
Income Tax Expense/Benefit	117.07% 2.191	-12.84	-5.83	5.996	11.05
Income/Loss From Continuing Operations After Tax	90.90% -4.105	-45.12	22.50	-11.83	15.33
Net Income/Loss	90.90% -4.105	-45.12	22.50	-11.83	15.33
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.44% 0.3172	56.55	56.02	55.86	0.1229
Diluted Average Shares	99.44% 0.3172	56.55	56.64	55.86	0.1674
Basic Earnings Per Share	91.25% -0.07	-0.80	0.40	-0.21	0.28
Diluted Earnings Per Share	91.25% -0.07	-0.80	0.40	-0.21	0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.94

1.15%

RGC

$23.23

3.21%

RDY

$14.13

1.53%

NBIX

$129.78

1.57%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%